Table 1 Baseline characteristics by gender of all COVID-19 cases referred to healthcare centres in Mashhad City from Feb 14, to May 11, 2020
Reference | All patients | Males | Females | p-value |
|---|---|---|---|---|
Number of patients (%) | 4000 (100) | 2352 (58.8) | 1648 (41.2) | Â |
Median age of the patients | 57.0 years | 56 .0 years | 58 .0 years | 0.0104* |
Age range | 39.0–71.0 | 39.0–70.0 | 39.0–73.0 | |
Days from onset to hospital admission | 2.0 | 2.0 | 2.0 | 0.9783 |
Range of days | 1.0–4.0 | 1.0–4.0 | 0.0–4.0 | |
Days from hospital admission to outcome | 5.0 | 5.0 | 5.0 | 0.4751 |
Range of days | 2.0–8.0 | 2.0–8.0 | 2.0–8.0 | |
Demographics & clinical characteristics | Number (%) | Number (%) | Number (%) | Â |
Co-morbidity | ||||
 Diabetes | 491 (12.27) | 252 (10.71) | 239 (14.50) | 0.0003* |
 CVD | 805 (20.12) | 404 (17.2) | 401 (24.3) | < 0.0001* |
 Liver disorders | 112 (2.80) | 61 (2.59) | 51 (3.09) | 0.3444 |
 CRD | 155 (3.87) | 95 (4.04) | 60 (3.64) | 0.5206 |
 Nervous diseases | 99 (2.47) | 64 (2.72) | 35 (2.12) | 0.2314 |
 COPD | 236 (5.90) | 115 (4.89) | 121 (7.34) | 0.0011* |
 Malignancy (any) | 99 (2.47) | 59 (2.50) | 40 (2.42) | 0.8706 |
Initial symptoms | ||||
 Fever | 2177 (54.42) | 1308 (55.61) | 869 (52.73) | 0.0716 |
 Cough | 2377 (59.42) | 1383 (58.80) | 994 (60.31) | 0.337 |
 Dyspnoea | 2777 (69.42) | 1606 (68.28) | 1171 (71.05) | 0.0609 |
 Weakness | 778 (19.45) | 452 (19.21) | 326 (19.78) | 0.6574 |
 Myalgia | 574 (14.35) | 331 (14.07) | 243 (14.74) | 0.5507 |
 Dizziness | 338 (8.45) | 206 (8.75) | 132 (8.0) | 0.4020 |
 Sore throat | 434 (10.85) | 262 (11.13) | 172 (10.43) | 0.4819 |
 Sputum | 74 (1.85) | 37 (1.57) | 37 (2.24) | 0.1206 |
 Diarrhoea | 137 (3.42) | 79 (3.35) | 58 (3.51) | 0.7834 |
 Nausea or vomiting | 332 (8.30) | 182 (7.74) | 150 (9.10) | 0.1238 |
 Headache | 325 (8.12) | 184 (7.82) | 141 (8.55) | 0.4038 |
 Chest pain | 318 (7.95) | 181 (7.70) | 137 (8.30) | 0.4773 |
 Abdominal pain | 70 (1.75) | 32 (1.36) | 38 (2.30) | 0.0248* |
 Arthralgia | 235 (5.87) | 133 (5.65) | 102 (6.19) | 0.4792 |
 Pharyngitis | 49 (1.22) | 27 (1.14) | 22 (1.33) | 0.5967 |
 Conjunctivitis | 30 (0.75) | 17 (0.72) | 13 (0.78) | 0.8117 |
 Abnormal chest X-ray | 1059 (26.47) | 617 (26.23) | 442 (26.82) | 0.6786 |
End-points | ||||
 ICU admission | 502 (12.55) | 307 (13.05) | 195 (11.83) | 0.2516 |
 Ventilator | 772 (19.30) | 449 (19.09) | 323 (19.59) | 0.6878 |
 Coma | 24 (0.60) | 16 (0.68) | 8 (0.48) | 0.4322 |
Exposure history (last 14 days) | ||||
 Travel | 83 (2.07) | 58 (2.46) | 25 (1.51) | 0.0382* |
 Exposed at medical centres | 323 (8.07) | 185 (7.86) | 138 (8.37) | 0.5615 |
 Exposed to possibly infected individuals | 267 (6.68) | 155 (6.59) | 112 (6.79) | 0.7973 |
 Exposed to animals | 175 (4.37) | 118 (5.02) | 57 (3.46) | 0.0177* |
 Being healthcare staff | 281 (7.03) | 158 (6.71) | 123 (7.46) | 0.3636 |
Disease severity | … | … | … | 0.0404* |
 General | 3228 (80.70) | 1927 (81.93) | 1301 (78.94) | … |
 Severe | 748 (18.70) | 414 (17.60) | 334 (20.27) | … |
 Critical | 24 (0.60) | 11 (0.47) | 13 (0.79) | … |
Disease outcome | … | … | … | 0.0437* |
 Non-survivor | 707 (17.67) | 430 (18.3) | 277 (16.8) | … |
 Survivor | 2236 (55.90) | 1334 (56.7) | 902 (54.7) | … |
 Ongoing care | 1057 (26.43) | 588 (25.0) | 469 (28.5) | … |
COVID-19 confirmation | … | … | … | 0.0118* |
 PCR confirmation | 1325 (33.1) | 816 (34.7) | 509 (30.9) | … |
 Clinical confirmation | 2675 (66.9) | 1536 (65.3) | 1139 (69.1) | … |